You have 9 free searches left this month | for more free features.

Multiple Myeloma

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Health Technology Intervention on Patient Activation in Multiple

Not yet recruiting
  • Multiple Myeloma in Relapse
  • +3 more
    • (no location specified)
    Jan 9, 2023

    Multiple Myeloma in Relapse Trial in Shenzhen (BCMA/GPRC5D double CAR-T)

    Recruiting
    • Multiple Myeloma in Relapse
    • BCMA/GPRC5D double CAR-T
    • Shenzhen, Guangdong, China
      Shenzhen Qianhai Shekou Free Trade Zone Hospital
    Sep 28, 2023

    Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • ISB 2001
    • Benowa, Queensland, Australia
      Pindara Private Hospital
    May 18, 2023

    Multiple Myeloma Trial in Wollongong (IBI3003)

    Not yet recruiting
    • Multiple Myeloma
    • Wollongong, New South Wales, Australia
      Wollongong Private Hospital
    Oct 18, 2023

    Multiple Myeloma, Relapse Multiple Myeloma Trial in Chicago (Belantamab mafodotin, Carfilzomib, Pomalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • Relapse Multiple Myeloma
    • Belantamab mafodotin
    • +3 more
    • Chicago, Illinois
      University of Chicago Medicine Comprehensive Cancer Center
    Mar 23, 2023

    Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Oct 25, 2023

    Smoldering Multiple Myeloma Trial (Selinexor)

    Not yet recruiting
    • Smoldering Multiple Myeloma
    • (no location specified)
    Oct 27, 2022

    New Echocardiographic Indicators in Treatment of Primary

    Not yet recruiting
    • Multiple Myeloma
    • Chemotherapy and/or autologous hematopoietic stem cell transplantation
    • (no location specified)
    Sep 18, 2023

    Belantamab Mafodotin Care Patterns in Relapsed and/or Refractory

    Not yet recruiting
    • Multiple Myeloma
    • Durham, North Carolina
      Duke University Medical Center
    Aug 8, 2023

    Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in Miami (Iberdomide, Carfilzomib, Daratumumab)

    Not yet recruiting
    • Refractory Multiple Myeloma
    • Relapsed Multiple Myeloma
    • Miami, Florida
      University of Miami
    May 31, 2023

    Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • Myeloma-Associated Amyloidosis
    • Saint Louis, Missouri
      Washington University School of Medicine
    Apr 6, 2023

    Real-world Usage of HyQvia in Multiple Myeloma Secondary

    Not yet recruiting
    • Multiple Myeloma
    • Secondary Immunodeficiency (SID)
    • No Intervention
    • (no location specified)
    May 19, 2023

    Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

    Recruiting
    • Multiple Myeloma in Remission
    • MM-specific universal CAR T cells
    • Shenzhen, Guangdong, China
    • +1 more
    Aug 23, 2023

    Relapsed or Refractory Multiple Myeloma Trial (Forimtamig, Carfilzomib, Daratumumab)

    Not yet recruiting
    • Relapsed or Refractory Multiple Myeloma
    • (no location specified)
    Sep 20, 2023

    Multiple Myeloma Trial in Saint Louis (Care transition, No care transition)

    Not yet recruiting
    • Multiple Myeloma
    • Care transition
    • No care transition
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 30, 2023

    Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma
    • Frailty
      • (no location specified)
      Oct 30, 2023

      Real-World Mapping Antithrombotic Regimens in MM Patients on

      Not yet recruiting
      • Multiple Myeloma
      • Diagnosis
        • (no location specified)
        Aug 31, 2023

        Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

        Recruiting
        • Multiple Myeloma
        • +2 more
        • Wuhan, Hubei, China
          Institute of Hematology, Union Hospital, Tongji Medical College,
        Nov 18, 2023

        Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

        Completed
        • Multiple Myeloma
        • Chronic Lymphocytic Leukemia
        • Myeloma Coach or CLL Coach Mobile App
        • Springboard Beyond Cancer informational website
        • Durham, North Carolina
          Duke University
        Jun 23, 2023

        AlvocadeĀ® (Bortezomib) Safety and Effectiveness Study

        Completed
        • Multiple Myeloma, Refractory
        • (no location specified)
        Aug 19, 2023

        Relapsed and Refractory Multiple Myeloma Trial in Pittsburgh (Mezigdomide, Ixazomib, Dexamethasone)

        Not yet recruiting
        • Relapsed and Refractory Multiple Myeloma
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Sep 15, 2023

        Relapsed or Refractory Multiple Myeloma Trial in Tianjin (YTS104 Cells injection)

        Not yet recruiting
        • Relapsed or Refractory Multiple Myeloma
        • YTS104 Cells injection
        • Tianjin, Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Jun 13, 2023

        Smoldering Multiple Myeloma Trial in Rochester (Denosumab)

        Active, not recruiting
        • Smoldering Multiple Myeloma
        • Rochester, New York
          University of Rochester
        Oct 3, 2022

        Multiple Myeloma Trial in Canton (Lenalidomide)

        Recruiting
        • Multiple Myeloma
        • Canton, Ohio
          Gabrail Cancer & Research Center
        Oct 11, 2023

        Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

        Recruiting
        • Relapse/Refractory Multiple Myeloma
        • DeepTag-GPRC5D Targeted CAR T-cells
        • Hangzhou, Zhejiang, China
          The first affiliated hospital of medical college of zhejiang uni
        Oct 10, 2023